Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma C Stuart

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Life Sciences|March 29, 2008
The combination of raloxifene and epigallocatechin gallate suppresses growth and induces apoptosis in MDA-MB-231 cellsEmma C Stuart, Rhonda J Rosengren
International Journal of Oncology|May 10, 2007
Potential mechanisms for the synergistic cytotoxicity elicited by 4-hydroxytamoxifen and epigallocatechin gallate in MDA-MB-231 cellsEmma C Stuart, Lesley Larsen, Rhonda J Rosengren
Oncology Reports|July 29, 2010
In vitro mechanism of action for the cytotoxicity elicited by the combination of epigallocatechin gallate and raloxifene in MDA-MB-231 cellsEmma C Stuart, Reagan M Jarvis, Rhonda J Rosengren
Life Sciences|September 2, 2006
Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancerEmma C Stuart, Marissa J Scandlyn, Rhonda J Rosengren
Expert Opinion on Drug Metabolism & Toxicology|June 5, 2008
Sex-specific differences in CYP450 isoforms in humansMarissa J Scandlyn, Emma C Stuart, Rhonda J Rosengren
International Journal of Cancer|December 22, 2007
The combination of epigallocatechin gallate and curcumin suppresses ER alpha-breast cancer cell growth in vitro and in vivoTiffany J Somers-Edgar, Marissa J Scandlyn, Emma C Stuart, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Life Sciences|March 29, 2008
The combination of raloxifene and epigallocatechin gallate suppresses growth and induces apoptosis in MDA-MB-231 cellsEmma C Stuart, Rhonda J Rosengren
International Journal of Oncology|May 10, 2007
Potential mechanisms for the synergistic cytotoxicity elicited by 4-hydroxytamoxifen and epigallocatechin gallate in MDA-MB-231 cellsEmma C Stuart, Lesley Larsen, Rhonda J Rosengren
Oncology Reports|July 29, 2010
In vitro mechanism of action for the cytotoxicity elicited by the combination of epigallocatechin gallate and raloxifene in MDA-MB-231 cellsEmma C Stuart, Reagan M Jarvis, Rhonda J Rosengren
Life Sciences|September 2, 2006
Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancerEmma C Stuart, Marissa J Scandlyn, Rhonda J Rosengren
Expert Opinion on Drug Metabolism & Toxicology|June 5, 2008
Sex-specific differences in CYP450 isoforms in humansMarissa J Scandlyn, Emma C Stuart, Rhonda J Rosengren
International Journal of Cancer|December 22, 2007
The combination of epigallocatechin gallate and curcumin suppresses ER alpha-breast cancer cell growth in vitro and in vivoTiffany J Somers-Edgar, Marissa J Scandlyn, Emma C Stuart, et al.
Pageof 1